Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial
The ASPIRIN Neurodevelopmental Follow-up Trial aimed to assess the impact of antenatal low-dose aspirin on the neurodevelopment of children whose mothers participated in the original ASPIRIN trial. The study enrolled 620 children across multiple sites in low- and middle-income countries, focusing on cognitive, language, and motor development outcomes at 36 months of age.
Indication: Neurodevelopmental Abnormality
Modality: small molecule
Target: Neurodevelopmental Abnormality
Sponsor: NICHD Global Network for Women's and Children's Health
Source URL: ClinicalTrials.gov
Source updated: Oct 21, 2024
Ingested: May 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Neurodevelopmental Abnormality
View original source fields
Condition raw: Neurodevelopmental Abnormality
Condition normalized: Neurodevelopmental Abnormality
Modality raw: Neurodevelopmental Abnormality
Modality normalized: small molecule
Target raw: Neurodevelopmental Abnormality
Target normalized: Neurodevelopmental Abnormality